- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Exploring the Impact of Bronchiectasis Exacerbations
Panelists discuss how bacterial infections, environmental triggers, and microbiome imbalances cause bronchiectasis exacerbations, leading to increased cough, phlegm, fatigue, and hemoptysis.
EP: 1.Common Symptoms Seen With Bronchiectasis
EP: 2.Examining The Pathophysiology Of Bronchiectasis
EP: 3.Exploring the Impact of Bronchiectasis Exacerbations
EP: 4.Analyzing Treatment-Refractory Patients
EP: 5.Common Causes of Bronchiectasis
EP: 6.Airway Clearance Techniques and Antibiotics for Patients With Bronchiectasis
EP: 7.Unmet Needs for Bronchiectasis Exacerbations
EP: 8.Ideal Candidates for Bronchiectasis Surgeries
EP: 9.Preventive Strategies and Emerging Therapies for Bronchiectasis
EP: 10.Current Challenges in the Management of Bronchiectasis
EP: 11.The Effects of the Heterogeneity of Bronchiectasis
EP: 12.Novel Treatment Options for Bronchiectasis
EP: 13.Important Clinical Considerations for Patients With Bronchiectasis
EP: 14.Final Thoughts on Bronchiectasis Management
Clinical Brief: Causes and Management of Bronchiectasis Exacerbations
Main Discussion Topics
- Exacerbations are commonly triggered by bacterial infections, viral etiologies, and environmental factors.
- Impaired mucosal clearance significantly contributes to recurrent exacerbations.
- Management approaches include multiple modalities targeting different aspects of the disease.
Key Points for Physicians
- Monitor for increased cough, phlegm, fatigue, and hemoptysis as signs of exacerbation.
- Treatment options include:
- Oral, intravenous, or inhaled antibiotics based on severity
- Airway clearance devices (Vest, oscillating positive expiratory pressure devices like AerobikA/Acapella)
- Breathing techniques and mechanical assistance
- Anti-inflammatory approaches (DPP1 inhibitors, inhaled corticosteroids for eosinophilic phenotype)
- Consider surgical intervention for refractory cases
Notable Insights
Comprehensive management must address multiple dimensions, including infection control, inflammation reduction, mucus clearance enhancement, and hydration.
Clinical Significance
Effective bronchiectasis exacerbation management requires targeted multimodal therapies addressing both immediate symptoms and underlying mechanisms to prevent recurrence.
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More
Immune Checkpoint Inhibitors More Effective vs Bevacizumab in Nonsquamous NSCLC
August 6th 2025Bevacizumab combined with chemotherapy was not as effective in advanced driver gene-negative nonsquamous non–small cell lung cancer (NSCLC) compared with immune checkpoint inhibitors plus chemotherapy.
Read More
